Dr. Matson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1000 Westgate Drive
Suite 149
Saint Paul, MN 55114Phone+1 651-641-2924Fax+1 651-641-2901- Is this information wrong?
Education & Training
- Hennepin HealthcareFellowship, Nephrology, 1989 - 1991
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1986 - 1989
- University of Minnesota Medical SchoolClass of 1986
Certifications & Licensure
- MN State Medical License 2007 - 2024
- WA State Medical License 2003 - 2008
- IA State Medical License 1991 - 2006
- ID State Medical License 2003 - 2005
- WI State Medical License 1987 - 1991
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Start of enrollment: 2010 Sep 01
- Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus Start of enrollment: 2010 Nov 01
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsImmune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.Nandita Bose, Nadine R. Ottoson, Xiaohong Qiu, Ben Harrison, Jamie Lowe, Mark T. Uhlik, Blaine Rathmann, Takashi O Kangas, Lindsay R Jordan, Kathleen E. Ertelt, Adria ...> ;Journal of Immunology. 2019 May 15
- 2 citationsImmune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labial...Hugh McTavish, Katherine W. Zerebiec, Jay C. Zeller, Laurie L. Shekels, Mark A. Matson, Betsy T. Kren> ;Immunity, Inflammation and Disease. 2019 Mar 1
- 32 citationsPharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy PatientsMarc L. Reitman, Victor Dishy, Allison Moreau, William S. Denney, Chengcheng Liu, Walter K. Kraft, Alex Mejia, Mark A. Matson, S. Aubrey Stoch, John A. Wagner, Eseng Lai> ;Journal of Clinical Pharmacology. 2012 Sep 1
- Join now to see all
Press Mentions
- Injection Lowers Cholesterol in Preliminary Human TrialNovember 30th, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: